Manufacturers Notice of Registration - 2004
FR Doc 04-5771 [Federal Register: March 15, 2004 (Volume 69, Number 50)] [Notices] [Page 12181-12182] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr15mr04-114]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated November 14, 2003, and published in the Federal Register on December 2, 2003, (68 FR 67479), Sigma Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
|Lysergic acid diethylamide (7315)||I|
|3,4-Methylenedioxymethamphetamine (MDMA) (7405)||I|
|1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) (7470)||I|
The firm plans to manufacture the listed controlled substances for laboratory reference standards and neurochemicals.
No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Sigma Aldrich Research Biochemicals, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Sigma Aldrich Research Biochemicals, Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.
Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
[FR Doc. 04-5771 Filed 3-12-04; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).